TNFR2 Human, Sf9

Tumor Necrosis Factor Receptor Type 2 Human Recombinant, Sf9
Cat. No.
BT27034
Source
Sf9, Baculovirus cells.
Synonyms
Tumor Necrosis Factor Receptor Superfamily, Member 1B, TNFR2, TNFBR, Tumor Necrosis Factor Receptor Type II, Tumor Necrosis Factor Receptor 2, P80 TNF-Alpha Receptor, TNF-RII, TNF-R2, P75, Tumor Necrosis Factor Receptor Superfamily Member 1B, Tumor Necrosis Factor Binding Protein 2, Tumor Necrosis Factor Beta Receptor, Soluble TNFR1B Variant 1, P75 TNF Receptor, CD120b Antigen, Etanercept, TNF-R-II, TNF-R75, P75TNFR, TNFR-II, CD120b, TNFR1B, TNFR80, TBPII.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

TNFR2 produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain (23-257 a.a.) and fused to a 6 aa His Tag at C-terminus containing a total of 241 amino acids and having a molecular mass of 25.9kDa.
TNFR2 shows multiple bands between 28-40kDa on SDS-PAGE, reducing conditions and purified by proprietary chromatographic techniques.

Product Specs

Introduction
TNFR2, a member of the TNF-receptor superfamily, exhibits a high affinity for TNFSF2/TNF-alpha and a five-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-alpha. This receptor plays a crucial role in mediating the metabolic effects of TNF-alpha. Studies conducted on knockout mice suggest that TNFR2 protects neurons from apoptosis by activating antioxidative pathways. Furthermore, TNFR2 expression may be implicated in angiogenesis, tumor cell proliferation, and metastasis in Invasive micropapillary carcinoma of the breast. Soluble TNF receptors, namely sTNFR-I and sTNFR-II, neutralize the biological activities of TNF alpha and TNF beta. These soluble receptors are believed to be generated through the shedding of the extracellular domains of their membrane-bound counterparts. Elevated levels of soluble TNF receptors have been observed in the amniotic fluid of pregnant women. TNFR2 and TNFR1 interact to form a heterocomplex that facilitates the recruitment of two anti-apoptotic proteins, c-IAP1 and c-IAP2, both of which possess E3 ubiquitin ligase activity. Although the precise function of IAPs in TNF-receptor signaling remains elusive, c-IAP1 is thought to enhance TNF-induced apoptosis by ubiquitinating and degrading TNF-receptor-associated factor 2, a mediator of anti-apoptotic signals. Oxidative stress has been shown to promote TNFR1 and TNFR2 self-interaction, leading to ligand-independent and enhanced ligand-dependent TNF signaling. TNF-a, TNFR1, and TNFR2 play important roles in cellular differentiation and cell type-specific renal injury.
Description
TNFR2, a product of Sf9 Baculovirus cell expression, is a single, glycosylated polypeptide chain. This protein consists of amino acids 23-257 of TNFR2 fused to a C-terminal 6 aa His Tag, resulting in a total of 241 amino acids and a molecular mass of 25.9 kDa. SDS-PAGE analysis under reducing conditions reveals multiple bands for TNFR2 between 28-40 kDa. The protein has been purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The TNFR2 protein solution is provided at a concentration of 1 mg/ml in a buffer consisting of Phosphate buffered saline (pH 7.4) and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the TNFR2 protein should be stored at 4°C. For extended storage, freezing at -20°C is recommended. To ensure optimal stability during long-term storage, the addition of a carrier protein (0.1% HSA or BSA) is advised. Avoid repeated freeze-thaw cycles.
Purity
The purity of TNFR2 is greater than 95.0%, as determined by SDS-PAGE analysis.
Synonyms
Tumor Necrosis Factor Receptor Superfamily, Member 1B, TNFR2, TNFBR, Tumor Necrosis Factor Receptor Type II, Tumor Necrosis Factor Receptor 2, P80 TNF-Alpha Receptor, TNF-RII, TNF-R2, P75, Tumor Necrosis Factor Receptor Superfamily Member 1B, Tumor Necrosis Factor Binding Protein 2, Tumor Necrosis Factor Beta Receptor, Soluble TNFR1B Variant 1, P75 TNF Receptor, CD120b Antigen, Etanercept, TNF-R-II, TNF-R75, P75TNFR, TNFR-II, CD120b, TNFR1B, TNFR80, TBPII.
Source
Sf9, Baculovirus cells.
Amino Acid Sequence
LPAQVAFTPY APEPGSTCRL REYYDQTAQM CCSKCSPGQH AKVFCTKTSD TVCDSCEDST YTQLWNWVPE CLSCGSRCSS DQVETQACTR EQNRICTCRP GWYCALSKQE GCRLCAPLRK CRPGFGVARP GTETSDVVCK PCAPGTFSNT TSSTDICRPH QICNVVAIPG NASMDAVCTS TSPTRSMAPG AVHLPQPVST RSQHTQPTPE PSTAPSTSFL LPMGPSPPAE GSTGDHHHHH H

Product Science Overview

Introduction

Tumor Necrosis Factor Receptor Type 2 (TNFR2), also known as TNFRSF1B or CD120b, is a member of the tumor necrosis factor receptor superfamily. TNFR2 is one of the two receptors that bind to tumor necrosis factor-alpha (TNFα), a cytokine involved in systemic inflammation and the acute phase reaction . The recombinant form of TNFR2, produced in Sf9 insect cells, is used in various research and therapeutic applications.

Structure and Function

TNFR2 consists of an extracellular region with four cysteine-rich domains that allow for binding to TNFα . Unlike its counterpart TNFR1, TNFR2 lacks a death domain (DD), which results in different intracellular signaling pathways and functions . TNFR2 has a high affinity for TNFα and mediates several metabolic effects of this cytokine .

Role in Tumor Biology

TNFR2 is expressed in various tumor cells and immune cells, such as regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) . It plays a significant role in the tumor microenvironment by promoting tumor growth, activating immunosuppressive cells, and supporting immune escape . TNFR2 can act as an oncogene, but it also has antitumoral activities by co-stimulating cytotoxic T-cells .

Therapeutic Potential

Given its dual role in tumor biology, TNFR2 is considered a promising target for cancer therapy. Both antagonists and agonists targeting TNFR2 have shown anti-tumor activity in preclinical studies . The therapeutic potential of TNFR2 lies in its ability to modulate the immune response and affect tumor progression and metastasis .

Recombinant TNFR2 (Human, Sf9)

The recombinant form of TNFR2 produced in Sf9 insect cells is used for research and therapeutic purposes. This recombinant protein retains the functional properties of the native receptor and is used to study TNFR2-related signaling pathways and to develop targeted therapies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.